Sunbin Ling

2.3k total citations
50 papers, 1.4k citations indexed

About

Sunbin Ling is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Sunbin Ling has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Oncology and 15 papers in Surgery. Recurrent topics in Sunbin Ling's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Ubiquitin and proteasome pathways (6 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Sunbin Ling is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Ubiquitin and proteasome pathways (6 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Sunbin Ling collaborates with scholars based in China, United States and Madagascar. Sunbin Ling's co-authors include Shusen Zheng, Qianwei Ye, Xiao Xu, Tingting Feng, Qiaonan Shan, Haiyang Xie, Xuyong Wei, Shengjun Xu, Penghong Song and Kangchen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Blood.

In The Last Decade

Sunbin Ling

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunbin Ling China 19 790 533 402 265 232 50 1.4k
Le‐Qun Li China 20 685 0.9× 542 1.0× 598 1.5× 229 0.9× 312 1.3× 63 1.5k
Thomas Amann Germany 17 806 1.0× 238 0.4× 452 1.1× 329 1.2× 284 1.2× 28 1.4k
Juanjuan Shan China 24 1.4k 1.8× 635 1.2× 735 1.8× 172 0.6× 191 0.8× 41 2.1k
Chris K. Sun Hong Kong 23 791 1.0× 299 0.6× 316 0.8× 208 0.8× 333 1.4× 25 1.4k
Chuangye Han China 24 790 1.0× 318 0.6× 644 1.6× 196 0.7× 158 0.7× 89 1.5k
Limei Liu China 22 1.1k 1.4× 565 1.1× 507 1.3× 148 0.6× 138 0.6× 42 1.7k
Miriam Farina Italy 10 837 1.1× 332 0.6× 393 1.0× 209 0.8× 241 1.0× 20 1.5k
Changwei Dou China 22 1.2k 1.5× 334 0.6× 852 2.1× 198 0.7× 199 0.9× 46 1.8k
JiHoon Kang South Korea 21 642 0.8× 493 0.9× 476 1.2× 136 0.5× 63 0.3× 63 1.4k

Countries citing papers authored by Sunbin Ling

Since Specialization
Citations

This map shows the geographic impact of Sunbin Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunbin Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunbin Ling more than expected).

Fields of papers citing papers by Sunbin Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunbin Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunbin Ling. The network helps show where Sunbin Ling may publish in the future.

Co-authorship network of co-authors of Sunbin Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Sunbin Ling. A scholar is included among the top collaborators of Sunbin Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunbin Ling. Sunbin Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jiong-Jie, Damiano Buratto, Wei Chen, et al.. (2024). Unveiling the Role of Mechanical Microenvironment in Hepatocellular Carcinoma: Molecular Mechanisms and Implications for Therapeutic Strategies. International Journal of Biological Sciences. 20(13). 5239–5253. 3 indexed citations
2.
Liu, Peng, Zhuang Li, Sunbin Ling, et al.. (2024). mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma. Molecular Biomedicine. 5(1).
3.
Liu, Yanpeng, Siyu Chen, Yidan Shen, et al.. (2024). Rapamycin-loaded nanoparticles elicit local liver immunosuppressive and remote anti-tumor efficacy. Nano Today. 61. 102589–102589. 3 indexed citations
4.
Bao, Jiaqi, Yudi Zhao, Xiao Xu, & Sunbin Ling. (2024). Advances in the Use of Metformin for Liver Disease. Current Medicinal Chemistry. 32(18). 3591–3605. 8 indexed citations
5.
Ling, Sunbin, et al.. (2022). Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastrointestinal Surgery. 14(5). 397–408. 1 indexed citations
6.
Wei, Xuyong, Sunbin Ling, Kai Wang, et al.. (2022). A mixed blessing for liver transplantation patients — Rapamycin. Hepatobiliary & pancreatic diseases international. 22(1). 14–21. 12 indexed citations
7.
Wei, Rongli, Kangchen Chen, Wenhui Zhang, et al.. (2022). Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 22(3). 228–238. 3 indexed citations
8.
Feng, Tingting, Yan Zhang, Sunbin Ling, et al.. (2021). PDZ Binding Kinase/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors. Journal of Oncology. 2021. 1–16. 6 indexed citations
9.
Feng, Tingting, Sunbin Ling, Chenyang Xu, et al.. (2021). Ubiquitin-specific peptidase 22 in cancer. Cancer Letters. 514. 30–37. 42 indexed citations
11.
He, Xin, Zijie Feng, Jian Ma, et al.. (2021). CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch. Leukemia. 35(11). 3309–3313. 12 indexed citations
12.
He, Xin, Zijie Feng, Jian Ma, et al.. (2020). Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia. Blood. 135(10). 713–723. 155 indexed citations
13.
Zhan, Qifan, Sunbin Ling, Yinan Deng, et al.. (2020). Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & pancreatic diseases international. 19(4). 349–357. 18 indexed citations
14.
Xing, Bowen, Jian Ma, Zongzhe Jiang, et al.. (2019). GLP-1 signaling suppresses menin’s transcriptional block by phosphorylation in β cells. The Journal of Cell Biology. 218(3). 855–870. 9 indexed citations
15.
Ye, Qianwei, et al.. (2019). Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer. 18(1). 114–114. 287 indexed citations
16.
Feng, Tingting, et al.. (2019). Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma. World Journal of Surgical Oncology. 17(1). 54–54. 45 indexed citations
17.
Ling, Sunbin, Jie Li, Qiaonan Shan, et al.. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Molecular Oncology. 11(6). 682–695. 84 indexed citations
18.
Ling, Sunbin, Qiaonan Shan, Peng Liu, et al.. (2017). Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death and Disease. 8(11). e3159–e3159. 51 indexed citations
19.
Ling, Sunbin, Tingting Feng, Qinghong Ke, et al.. (2014). Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines. Oncology Reports. 31(6). 2611–2618. 55 indexed citations
20.
Ling, Sunbin, et al.. (2014). Inflammation to cancer: The molecular biology in the pancreas (Review). Oncology Letters. 7(6). 1747–1754. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026